TY - JOUR
T1 - The role of serum amylase in the diagnosis of acute pelvic inflammatory disease
AU - Counselman, Francis L.
AU - Elder, Donna M.
AU - Brandecker, J. Gary
AU - Silverman, Michael A.
AU - Entwistle, Celia B.
AU - Hubbard, Margaret M.
AU - Weiseman, Jane Stansel
N1 - Funding Information:
From the Department of Emergency Medicine, Eastern Virginia Graduate School of Medicine and the Emergency Physicians of Tidewater, Norfolk, VA. Manuscript received November 2, 1992; revision accepted February 5, 1993. This study was supported by a grant from Roche Laboratories, a Division of Hoffmann-La Roche, Inc, Nutley, NJ. Address reprint requests to Dr Counselman, Department of Emergency Medicine, Room 204 Raleigh Building, 600 Gresham Dr, Norfolk, VA 23507. Key Words: Pelvic inflammatory amylase. Copyright @ 1993 by W.B. Saunders Company 0735-6757/93/1105-0004$5.00/O
PY - 1993/9
Y1 - 1993/9
N2 - The use of serum amylase levels in the diagnosis of acute pelvic inflammatory disease (PID) was investigated prospectively. Eighty-five women presenting with the chief complaint of lower abdominal pain were entered into the study; all patients were examined by one of the principal investigators. In addition to the usual laboratory studies, a serum amylase level was obtained on all patients; the investigators were blinded to the results. Patients were diagnosed with PID if they fulfilled previously published clinical criteria. Forty-eight patients met the criteria for the diagnosis of PID (PID group); 37patients were diagnosed with other disease processes (non-PID group). The average serum amylase level for the PID group was 62 U/L, with a standard deviation (STD) of 24; for the non-PID group, the average was 76 U/L with an STD of 32. Although there was a statistical difference between the two groups (P < .05), there was no clinically significant difference because both values fell within the normal range of serum amylase. The routine use of serum amylase in the diagnosis of acute PID seems to be of no value.
AB - The use of serum amylase levels in the diagnosis of acute pelvic inflammatory disease (PID) was investigated prospectively. Eighty-five women presenting with the chief complaint of lower abdominal pain were entered into the study; all patients were examined by one of the principal investigators. In addition to the usual laboratory studies, a serum amylase level was obtained on all patients; the investigators were blinded to the results. Patients were diagnosed with PID if they fulfilled previously published clinical criteria. Forty-eight patients met the criteria for the diagnosis of PID (PID group); 37patients were diagnosed with other disease processes (non-PID group). The average serum amylase level for the PID group was 62 U/L, with a standard deviation (STD) of 24; for the non-PID group, the average was 76 U/L with an STD of 32. Although there was a statistical difference between the two groups (P < .05), there was no clinically significant difference because both values fell within the normal range of serum amylase. The routine use of serum amylase in the diagnosis of acute PID seems to be of no value.
KW - Pelvic inflammatory disease
KW - salpingitis
KW - serum amylase
UR - http://www.scopus.com/inward/record.url?scp=0027178586&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027178586&partnerID=8YFLogxK
U2 - 10.1016/0735-6757(93)90081-L
DO - 10.1016/0735-6757(93)90081-L
M3 - Article
C2 - 7689845
AN - SCOPUS:0027178586
SN - 0735-6757
VL - 11
SP - 453
EP - 455
JO - American Journal of Emergency Medicine
JF - American Journal of Emergency Medicine
IS - 5
ER -